Get the Stockscreener App
40.67
1.31%
0.5273
After Hours:
40.66
-0.0073
-0.02%
Innovator Ibd R Breakout Opportunities Etf stock is traded at $40.67, with a volume of 3,717.
It is up +1.31% in the last 24 hours and up +9.37% over the past month.
See More
Previous Close:
$40.14
Open:
$40.3635
24h Volume:
3,717
Relative Volume:
1.50
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.06%
1M Performance:
+9.37%
6M Performance:
+14.80%
1Y Performance:
+32.81%
1-Day Range:
$40.29
$40.69
1-Week Range:
$38.50
$40.69
52-Week Range:
$30.52
$40.69
Innovator Ibd R Breakout Opportunities Etf Stock (BOUT) Company Profile
Name
Innovator Ibd R Breakout Opportunities Etf
Sector
Industry
Phone
-
Address
-
Compare BOUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| BOUT | 40.67 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Innovator Ibd R Breakout Opportunities Etf Stock (BOUT) Latest News
(BOUT) Long Term Investment Analysis - Stock Traders Daily
(BOUT) Proactive Strategies - Stock Traders Daily
(BOUT) Trading Signals - Stock Traders Daily
Objective long/short (BOUT) Report - Stock Traders Daily
Learn How To Time The Market With IBD’s ETF Market Strategy - Investor's Business Daily
(BOUT) Investment Report - Stock Traders Daily
2 ETFs That Could DOUBLE in the Next Few Years - sharewise
Forget Nvidia And Apple. Top Funds Can't Get Enough Of This Boring Stock. - Investor's Business Daily
Just A Glitch? Netflix, Apple Lead Breakout Stocks Hitting A Snag - Investor's Business Daily
(BOUT) Investment Analysis and Advice - Stock Traders Daily
Forget Amazon And Tesla. This Non-Magnificent Seven Stock Dwarfs Their Gains. - Investor's Business Daily
Step Aside, Tesla. This Stock Wants Your Mag 7 Card. - Investor's Business Daily
Breakout Watch: Medical Stock In Buy Range, Notches All-Time High - Investor's Business Daily
Kidney Care Leader Marches Toward Buy Point With 2 Sector Peers In Tow - Investor's Business Daily
(BOUT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
ServiceNow And This IPO Show How To Swim With 'Sharks' In Stormy Seas - Investor's Business Daily
While Nvidia Seeks Traction, This Stock Paves A Path Into Buy Range And Beyond - Investor's Business Daily
As CrowdStrike Crashes, This Cybersecurity Giant Uses AI To Fight AI - Investor's Business Daily
When the Price of (BOUT) Talks, People Listen - Stock Traders Daily
Palantir Peer And Microsoft Partner Rakes In Cash From Top Funds - Investor's Business Daily
AI Stock Launches A Breakout As Microsoft, Nvidia Fuel Gains - Investor's Business Daily
Google, Palantir, Netflix Spearhead This Breakout Brigade - Investor's Business Daily
The Stock Market Is Acting A Little Tired - Seeking Alpha
Trend Tracker for (BOUT) - Stock Traders Daily
Nvidia Ebbs And Flows. But Top Funds Love This Stock. - Investor's Business Daily
Kaspi Stock: IPO Leader Takes On PayPal, Amazon In Central Asia, Targets Breakout - Investor's Business Daily
Ralph Lauren In Fashion On Wall Street Alongside Nvidia, Google - Investor's Business Daily
Innovator Ibd R Breakout Opportunities Etf Stock (BOUT) Financials Data
There is no financial data for Innovator Ibd R Breakout Opportunities Etf (BOUT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):